Skip to main content

Want a detailed portfolio tracker?

Decoy Therapeutics (SLRX) P/E (2019 - 2026)

Decoy Therapeutics (SLRX) P/E from Sep 30, 2019 to Jan 7, 2026. The TTM Decoy Therapeutics (SLRX) P/E is -0.01. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Decoy Therapeutics (SLRX)

YearP/EChange
2026-0.01+29.47%
2025-0.01-99.11%
2024-0.97+854.69%
2023-0.10-57.52%
2022-0.24-98.65%
2021-17.70-45.54%
2020-32.51-75.93%
2019-135.03N/A

Comparison Decoy Therapeutics (SLRX) P/E with competitors

Decoy Therapeutics (SLRX) P/E is -0.01.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-115.14%
NBYStablecoin Development Corp0.00-138.30%
ENLVEnlivex Ltd0.07-766.21%
FGENFibroGen Inc0.24-2237.86%
CHRSCoherus Biosciences Inc0.85-7657.17%
FBIOFortress Biotech Inc0.95-8552.27%
ORMPOramed Pharmaceuticals Inc1.50-13486.48%
AGENAgenus Inc3.01-26904.13%
INVAInnoviva Inc3.15-28190.23%
VXRTVaxart Inc3.55-31714.53%
CRMDCorMedix Inc3.63-32415.47%
CVACCureVac N.V.4.45-39693.87%
GLPGGalapagos NV4.86-43374.03%
SRPTSarepta Therapeutics Inc4.88-43580.67%
ABEOAbeona Therapeutics Inc5.39-48082.01%
ABUSArbutus Biopharma Corp5.60-49935.46%
ZVRAZevra Therapeutics Inc5.89-52532.59%
SPROSpero Therapeutics Inc6.23-55571.49%
CGENCompugen Ltd6.31-56333.00%
RIGLRigel Pharmaceuticals6.87-61303.72%
SLXNSilexion Therapeutics Corp7.30-65080.08%
OMEROmeros Corporation9.26-82559.98%
AUPHAurinia Pharmaceuticals Inc9.58-85465.28%
PLXProtalix BioTherapeutics Inc10.89-97097.18%
ACADAcadia Pharmaceuticals Inc11.73-104556.38%
TBPHTheravance Biopharma Inc12.26-109308.89%
ADMAAdma Biologics Inc12.42-110698.30%
HRMYHarmony Biosciences Holdings Inc13.82-123185.22%
SABSSAB Biotherapeutics Inc14.14-125999.68%
NAGENiagen Bioscience Inc14.82-132073.02%
INCYIncyte Corp15.82-141018.72%
REGNRegeneron Pharmaceuticals Inc15.86-141322.43%
PBYIPuma Biotechnology Inc17.32-154317.02%
CPRXCatalyst Pharmaceuticals Inc17.44-155417.86%
EXELExelixis Inc17.54-156296.93%
TGTXTG Therapeutics Inc18.97-169015.42%
MDXGMimedx Group Inc20.55-183144.70%
XOMAXOMA Royalty Corp22.87-203831.84%
ARGXArgen X SE24.30-216508.47%
CTMXCytomX Therapeutics Inc24.82-221167.46%
XOMAOXOMA Royalty Corp25.34-225831.80%
HALOHalozyme Therapeutics Inc25.62-228315.82%
XOMAPXOMA Royalty Corp25.67-228729.08%
VRTXVertex Pharmaceuticals Inc27.99-249433.14%
RPRXRoyalty Pharma plc - Class A28.69-255603.57%
ASNDAscendis Pharma A/S30.09-268054.86%
LGNDLigand Pharmaceuticals Inc - Class B37.91-337760.73%
APLSApellis Pharmaceuticals Inc39.02-347639.83%
BMRNBiomarin Pharmaceutical Inc42.21-376056.92%
KRYSKrystal Biotech Inc45.34-403948.53%
ONCBeiGene Ltd69.54-619457.44%
PHARPharming Group N.V.75.03-668310.51%
TECHBio-Techne Corp101.96-908185.84%
VCELVericel Corp109.92-979107.44%
ALNYAlnylam Pharmaceuticals Inc117.96-1050748.70%
GMABGenmab140.29-1249590.86%
TLXTelix Pharmaceuticals Ltd162.15-1444303.98%
CORTCorcept Therapeutics Inc212.86-1895902.06%